综述
ENGLISH ABSTRACT
春季角结膜炎的发病机制及治疗研究进展
李素霞
史伟云 [综述]
作者及单位信息
·
DOI: 10.3760/cma.j.cn115989-20220413-00159
Advance in mechanism and management study of vernal keratoconjunctivitis
Li Suxia
Shi Weiyun
Authors Info & Affiliations
Li Suxia
Eye Institute of Shandong First Medical University, Eye Hospital of Shandong First Medical University (Shandong Eye Hospital) State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, School of Ophthalmology, Shandong First Medical University, Jinan 250021, China
Shi Weiyun
Eye Institute of Shandong First Medical University, Eye Hospital of Shandong First Medical University (Shandong Eye Hospital) State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, School of Ophthalmology, Shandong First Medical University, Jinan 250021, China
·
DOI: 10.3760/cma.j.cn115989-20220413-00159
0
0
0
0
0
0
PDF下载
APP内阅读
摘要

春季角结膜炎(VKC)是一种慢性变应性角结膜炎,常见于学龄期儿童,临床上根据病变累及的组织分为睑结膜型、角膜缘型及混合型。尽管不同类型的变应性结膜炎大多数不引起视力下降,但VKC除了引起结膜病变外还可能发生角膜损害,进而导致视力下降,年龄较小的儿童一旦发生角膜损害还可能导致弱视。虽然VKC疾病名称似有季节性指向,但研究发现20%~60%的患者可能会全年发病,误诊或者不规范的治疗可引起病情迁延甚至导致眼部并发症。既往认为VKC是一种Ⅰ型和Ⅳ型超敏反应共同参与的疾病,目前发现免疫学因素、遗传因素和内分泌因素均参与疾病的发生和发展。VKC的诊断主要依据患者主观症状、角膜和结膜的特征性体征、激光共焦显微镜下组织中树突状细胞浸润和变应原检测试验。VKC的治疗以药物对症治疗为主,除了常规抗过敏、抗炎及人工泪液治疗,免疫抑制剂治疗成为新的趋势。本文对发病机制和治疗研究进展进行综述。

春季角结膜炎;发病机制;治疗
ABSTRACT

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral allergic conjunctivitis common in school children.VKC is classified into palpebral-conjunctival type, limbal type and mixed type primarily based on clinical findings.Most allergic conjunctivitis does not impair vision, however, VKC probably causes visual impairment because of the involvement of cornea besides conjunctiva.Corneal lesions of VKC would lead to amblyopia in younger children.The term "vernal" in VKC indicates a seasonal onset, but 20%-60% patients are found onset throughout the year.In addition, misdiagnosis and improper treatment often lead to persistence or recurrence of VKC and other complications.Previous study has suggested that VKC is a hypersensitivity disease involved both type I and type IV, however, recent researchers found that immune factor, genetic factor and endocrine factor show close associations with the pathogenesis of VKC.The diagnosis of VKC depends on the clinical symptoms, pathological findings, infiltration of dendritic cells by laser scanning confocal microscopy and allergen tests.The treatment of VKC mainly focuses on symptom relief.In addition to anti-allergy, anti-inflammation and artificial tears, immunosuppressor has become a new trend.The pathogenesis and treatment progress of VKC are reviewed.

Vernal keratoconjunctivitis;Pathogenesis;Therapy
引用本文

李素霞,史伟云. 春季角结膜炎的发病机制及治疗研究进展[J]. 中华实验眼科杂志,2022,40(05):481-486.

DOI:10.3760/cma.j.cn115989-20220413-00159

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
春季角结膜炎(vernal keratoconjunctivitis,VKC)是一种慢性、双眼反复发作的变态反应性疾病,多发于儿童,其发病与春季明显相关。VKC可表现为上睑结膜乳头增生和/或角膜巩膜缘典型乳头样上皮病变,严重者引起角膜病变,包括角膜混浊、角膜盾形溃疡等,导致视力下降,年龄较小的儿童发生角膜损害还可能导致弱视。不规范的治疗可引起病情迁延或反复发作。虽然VKC有明显的季节性倾向,但有报道20%~60%的患者为全年性发生 [ 1 , 2 , 3 ]。VKC的确切发病机制尚未完全阐明 [ 4 ],既往认为与IgE介导的I型超敏反应和T淋巴细胞介导的IV型超敏反应相关。近年来,对于VKC的流行病学、病理特征、临床特点、诊断等,尤其是发病机制和治疗的研究都取得了一定的进展。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Alemayehu AM , Yibekal BT , Fekadu SA . Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town,southwest Ethiopia,June 2018[J/OL]PLoS One 201914(4):e0215528[2022-01-18]http://www.ncbi.nlm.nih.gov/pubmed/30998721. DOI: 10.1371/journal.pone.0215528 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Marey HM , Mandour SS , El Morsy OA et al. Impact of vernal keratoconjunctivitis on school children in Egypt[J]Semin Ophthalmol 201732(5):543-549. DOI: 10.3109/08820538.2015.1123737 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Vichyanond P , Pacharn P , Pleyer U et al. Vernal keratoconjunctivitis:a severe allergic eye disease with remodeling changes[J]Pediatr Allergy Immunol 201425(4):314-322. DOI: 10.1111/pai.12197 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Esposito S , Fior G , Mori A et al. An update on the therapeutic approach to vernal keratoconjunctivitis[J]Paediatr Drugs 201618(5):347-355. DOI: 10.1007/s40272-016-0185-1 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Chigbu DI , Labib BA . Immunopharmacology in vernal keratoconjunctivitis:current and future perspectives[J/OL]Pharmaceuticals (Basel) 202114(7):658[2022-02-18]http://www.ncbi.nlm.nih.gov/pubmed/34358085. DOI: 10.3390/ph14070658 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Leonardi A , Busca F , Motterle L et al. Case series of 406 vernal keratoconjunctivitis patients:a demographic and epidemiological study[J]Acta Ophthalmol Scand 200684(3):406-410. DOI: 10.1111/j.1600-0420.2005.00622.x .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Dahal P , Bhattarai S Clinical presentation of vernal keratoconjunctivitis in Bharatpur Medical College[J]JCMS-Nepal 201511(2):17-19.
返回引文位置Google Scholar
百度学术
万方数据
[8]
西北五省(区)春季卡他性角结膜炎研究协作组西北地区春季卡他性角结膜炎流行病学研究[J]中华眼科杂志 198622(1):43-45.
返回引文位置Google Scholar
百度学术
万方数据
[9]
Feizi S , Javadi MA , Alemzadeh-Ansari M et al. Management of corneal complications in vernal keratoconjunctivitis:a review[J]Ocul Surf 202119:282-289. DOI: 10.1016/j.jtos.2020.10.005 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
姚娟李冰郑晓汾不同类型过敏性结膜炎患者眼表组织中白细胞介素-4、5和13的表达[J]中华实验眼科杂志 201533(10):924-929. DOI: 10.3760/cma.j.issn.2095-0160.2015.10.013 .
返回引文位置Google Scholar
百度学术
万方数据
Yao J , Li B , Zheng XF . Expressions of interleukin-4,5 and 13 in ocular surface with different types of allergic conjunctivitis[J]Chin J Exp Ophthalmol 201533(10):924-929. DOI: 10.3760/cma.j.issn.2095-0160.2015.10.013
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[11]
Leonardi A , Sathe S , Bortolotti M et al. Cytokines,matrix metalloproteases,angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients[J]Allergy 200964(5):710-717. DOI: 10.1111/j.1398-9995.2008.01858.x .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Leonardi A , Brun P , Abatangelo G et al. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis[J]Invest Ophthalmol Vis Sci 200344(7):3052-3058. DOI: 10.1167/iovs.02-0766 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Addis H , Jeng BH . Vernal keratoconjunctivitis[J]Clin Ophthalmol 201812:119-123. DOI: 10.2147/OPTH.S129552 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Liu M , Gao H , Wang T et al. An essential role for dendritic cells in vernal keratoconjunctivitis:analysis by laser scanning confocal microscopy [J]Clin Exp Allergy 201444(3):362-370. DOI: 10.1111/cea.12264 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Aali F , Barjui SP , Aali F et al. Investigation of the association between (CCTTT)n polymorphism in NOS2 gene and serum IgE level in patients with vernal keratoconjunctivitis in Chaharmahal va Bakhtiari Province [J]Gene Reports 201812:165-170. DOI: 10.1016/j.genrep.2018.06.010 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
De Smedt S , Wildner G , Kestelyn P Vernal keratoconjunctivitis:an update[J]Br J Ophthalmol 201397(1):9-14. DOI: 10.1136/bjophthalmol-2011-301376 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Al-Hakami AM , Al-Amri A , Abdulrahim I et al. Is there is an association between the presence of Staphylococcus species and occurrence of vernal keratoconjunctivitis? [J]Saudi J Ophthalmol 201529(4):255-258. DOI: 10.1016/j.sjopt.2015.05.002 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
李炜炜王智群张阳. 745例变应性结膜炎的临床特点[J]中华实验眼科杂志 201735(7):645-650. DOI: 10.3760/cma.j.issn.2095-0160.2017.07.015 .
返回引文位置Google Scholar
百度学术
万方数据
Li WW , Wang ZQ , Zhang Y et al. Clinical characteristics of 745 cases of allergicconjunctivitis[J]Chin J Exp Ophthalmol 201735(07):645-650. DOI: 10.3760/cma.j.issn.2095-0160.2017.07.015
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[19]
Ghiglioni DG , Zicari AM , Parisi GF et al. Vernal keratoconjunctivitis:an update[J]Eur J Ophthalmol 202131(6):2828-2842. DOI: 10.1177/11206721211022153 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Bruschi G , Ghiglioni D G , Osnaghi S et al. Role of ocular cytology in vernal keratoconjunctivitis[J]Immunity,inflammation and disease 20208(1):3-7.
返回引文位置Google Scholar
百度学术
万方数据
[21]
刘家琦李凤鸣实用眼科学[M]. 3版北京人民卫生出版社 2010264-265.
[22]
Azari AA , Arabi A Conjunctivitis:a systematic review[J]J Ophthalmic Vis Res 202015(3):372-395. DOI: 10.18502/jovr.v15i3.7456 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Feizi S , Javadi MA , Alemzadeh-Ansari M et al. Management of corneal complications in vernal keratoconjunctivitis:a review[J]Ocul Surf 202119:282-289. DOI: 10.1016/j.jtos.2020.10.005 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Reddy JC , Basu S , Saboo US et al. Management,clinical outcomes,and complications of shield ulcers in vernal keratoconjunctivitis[J]Am J Ophthalmol 2013155(3):550-559. DOI: 10.1016/j.ajo.2012.09.014 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Wajnsztajn D , Solomon A Vernal keratoconjunctivitis and keratoconus[J]Curr Opin Allergy Clin Immunol 202121(5):507-514. DOI: 10.1097/ACI.0000000000000765 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
吴开力李坤珂重视过敏性结膜炎的诊断与治疗[J]中华实验眼科杂志 201836(9):661-665. DOI: 10.3760/cma.j.issn.2095-0160.2018.09.002 .
返回引文位置Google Scholar
百度学术
万方数据
Wu KL , Li KK . Attaching importance to diagnosis and treatment of allergicconjunctivitis[J]Chin J Exp Ophthalmol 201836(9):661-665. DOI: 10.3760/cma.j.issn.2095-0160.2018.09.002 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[27]
中华医学会眼科学分会角膜病学组我国过敏性结膜炎诊断和治疗专家共识(2018年)[J]中华眼科杂志 201854(6):409-414. DOI: 10.3760/cma.j.issn.0412-4081.2018.06.003 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Kumar S , Gupta N , Vivian AJ . Modern approach to managing vernal keratoconjunctivitis[J]Curr Allergy Asthma Rep 201010(3):155-162. DOI: 10.1007/s11882-010-0101-7 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Manti S , Parisi GF , Papale M et al. Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis:our experience and literature review[J]Immun Inflamm Dis 20219(1):3-7. DOI: 10.1002/iid3.384 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Miyazaki D , Takamura E , Uchio E et al. Japanese guidelines for allergic conjunctival diseases 2020[J]Allergol Int 202069(3):346-355. DOI: 10.1016/j.alit.2020.03.005 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Leonardi A , Doan S , Amrane M et al. A randomized,controlled trial of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivitis:the VEKTIS study[J]Ophthalmology 2019126(5):671-681. DOI: 10.1016/j.ophtha.2018.12.027 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Bremond-Gignac D , Doan S , Amrane M et al. Twe lve-month results of cyclosporine A cationic emulsion in a randomized study in patients with pediatric vernal keratoconjunctivitis [J]Am J Ophthalmol 2020212:116-126. DOI: 10.1016/j.ajo.2019.11.020 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Rasmussen M , Schou MG , Bach-Holm D et al. Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults:a systematic review with network meta-analyses[J]Acta Ophthalmol 2022100(1):35-44. DOI: 10.1111/aos.14858 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Lallemand F , Daull P , Benita S et al. Successfully improving ocular drug delivery using the cationic nanoemulsion,novasorb[J/OL]J Drug Deliv 201 2 2012:604204[2022-03-02]http://www.ncbi.nlm.nih.gov/pubmed/22506123. DOI: 10.1155/2012/604204 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Pucci N , Caputo R , di Grande L et al. Tacrolimus vs.cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis:a randomized,comparative,double-blind,crossover study[J]Pediatr Allergy Immunol 201526(3):256-261. DOI: 10.1111/pai.12360 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Caputo R , Marziali E , de Libero C et al. Long-term safety and efficacy of tacrolimus 0.1% in severe pediatric vernal keratoconjunctivitis[J]Cornea 202140(11):1395-1401. DOI: 10.1097/ICO.0000000000002751 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Ohashi Y , Ebihara N , Fujishima H et al. A randomized,placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis[J]J Ocul Pharmacol Ther 201026(2):165-174. DOI: 10.1089/jop.2009.0087 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
李莹重视变态反应性结膜炎治疗中非甾体抗炎药物的应用[J]中华实验眼科杂志 201432(3):196-199. DOI: 10.3760/cma.j.issn.2095-0160.2014.03.002 .
返回引文位置Google Scholar
百度学术
万方数据
Li Y Consideration of application of non-steroidal anti-inflammatory drugs in the treatment of allergicconjunctivitis [J]Chin J Exp Ophthalmol 201432(3):196-199. DOI: 10.3760/cma.j.issn.2095-0160.2014.03.002 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[39]
AlHarkan DH . Management of vernal keratoconjunctivitis in children in Saudi Arabia[J]Oman J Ophthalmol 202013(1):3-12. DOI: 10.4103/ojo.OJO_263_2018 .
返回引文位置Google Scholar
百度学术
万方数据
[40]
Mahdy RA , Nada WM , Marei AA . Subcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitis[J]Cornea 201231(5):525-528. DOI: 10.1097/ICO.0b013e3181eae270 .
返回引文位置Google Scholar
百度学术
万方数据
[41]
Occasi F , Duse M , Nebbioso M et al. Vernal keratoconjunctivitis treated with omalizumab:a case series[J]Pediatr Allergy Immunol 201728(5):503-505. DOI: 10.1111/pai.12737 .
返回引文位置Google Scholar
百度学术
万方数据
[42]
中国健康管理协会接触镜安全监控与视觉健康专业委员会中国治疗用绷带镜临床应用专家共识(2019年)[J]中华眼科杂志 201955(6):405-412. DOI: 10.3760/cma.j.issn.0412-4081.2019.06.002 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
所有作者均声明不存在利益冲突
B
山东省重点研发计划 (2022CXGC010505)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号